Dow advances on strong producer prices

The Dow advanced to close sharply higher with the blue chip index surging 118 points to 24,504 on strong gains in producer prices. Nasdaq lost 12 points to 6,862.


On the upside


Proteostasis Therapeutics (Nasdaq: PTI) reported positive results from three studies, PTI-428, PTI-801 and PTI-808 to treat cystic fibrosis.


GlycoMimetics (Nasdaq: GLYC) reported upbeat updated data from the Phase 1/2 trial for GMI-1271 to treat relapsed/refractory acute myeloid leukemia.


Bargain hunters lifted shares of Syros Pharmaceuticals (Nasdaq: SYRS).


On the downside


Two of seven patients in Global Blood Therapeutics (Nasdaq: GBT) study of voxelotor died.


Kosmos Energy (NYSE: KOS) will plug its Lamantin-1 exploration well offshore Mauritania.


Casey's General Stores (Nasdaq: CASY) reported lower second quarter earnings.


In the broad market, declining issues outpaced advancers by a margin of 6 to 5 on the NYSE and by 5 to 4 on Nasdaq. The broader S&P 500 rose 4 points to 2,664. Bitcoin soared $321 to $17,113.


Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.